SeaStar Medical Holding ICU Income Statement (2020-2026)

NASDAQ ICU
$3.36 +0.02 (+0.59%)
As of: Aug 21, 2026 · 10:11 AM EDT
Income Statement Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Revenue & cost
Revenue (Quarter)
0.07M0.07M0.30M0.34M0.18M0.42M0.50M0.61M
Cost of Revenue (Quarter)
0.03M0.01M0.01M0.05M0.05M
Gross Profit (Quarter)
0.07M0.07M0.29M0.31M0.17M0.41M0.45M0.56M
Operating items
Research & Development (Quarter)
0.35M0.60M0.73M0.82M1.73M1.98M1.09M1.18M1.70M2.33M2.34M2.74M2.43M1.04M1.85M2.20M2.34M2.52M
Selling, General & Administrative (Quarter)
0.41M0.94M0.46M0.72M1.04M4.70M2.85M1.77M1.85M1.76M2.25M2.33M2.19M2.10M1.68M1.03M1.90M1.22M1.71M1.83M
Restructuring Costs (Quarter)
1.06M1.39M
Other Operating Expenses (Quarter)
-1.06M-1.39M2.19M
Operating Expenses (Quarter)
0.41M0.94M0.81M1.31M1.77M7.72M4.58M3.75M2.94M2.94M3.95M4.67M4.52M4.83M4.12M2.07M3.75M3.42M4.05M4.35M
Operating Income (Quarter)
-0.41M-3.70M-0.81M-1.31M-1.77M-7.72M-4.58M-3.75M-2.94M-2.94M-3.95M-4.67M-4.46M-4.77M-3.82M-1.76M-3.58M-3.02M-3.60M-3.79M
EBIT (Quarter)
-0.41M-3.70M-0.81M-1.31M-1.77M-7.72M-4.58M-3.75M-2.94M-2.94M-3.95M-4.67M-4.46M-4.77M-3.82M-1.76M-3.58M-3.02M-3.60M-3.79M
Non-operating items
Interest & Investment Income (Quarter)
0.00M0.01M0.00M0.07M0.36M0.03M0.06M0.02M0.05M0.04M0.11M0.12M0.09M0.07M
Other Non Operating Income (Quarter)
-0.19M0.41M-0.12M-2.52M1.31M-4.95M0.55M-8.75M1.44M7.53M0.05M-0.25M
Non Operating Income (Quarter)
-0.02M0.35M0.05M0.11M-0.24M0.09M0.06M
Net income details
EBT (Quarter)
-0.41M-3.69M-1.00M-0.90M-1.89M-8.39M-7.10M-2.44M-7.23M-9.46M-12.70M-3.23M-4.48M-4.42M-3.77M-2.00M-3.47M-2.90M-3.52M-3.73M
Tax Provisions (Quarter)
0.00M0.01M-0.01M0.00M0.00M0.00M0.00M
Profit After Tax (Quarter)
0.24M-4.56M-1.00M-0.90M-1.89M-8.39M-7.10M-2.45M-7.23M-9.46M-12.70M-3.24M-4.48M-4.42M-3.77M-2.00M-3.47M-2.95M-3.50M-3.73M
Income from Continuing Operations (Quarter)
-0.41M-3.69M-1.00M-0.90M-1.89M-8.39M-7.10M-2.45M-7.23M-9.46M-12.70M-3.24M-4.48M-4.42M-3.77M-2.00M-3.47M-2.90M-3.52M-3.73M
Consolidated Net Income (Quarter)
-0.41M-3.69M-1.00M-0.90M-1.89M-8.39M-7.10M-2.45M-7.23M-9.46M-12.70M-3.24M-4.48M-4.42M-3.77M-2.00M-3.47M-2.90M-3.52M-3.73M
Income towards Parent Company (Quarter)
-0.41M-3.69M-1.00M-0.90M-1.89M-8.39M-7.10M-2.45M-7.23M-9.46M-12.70M-3.24M-4.48M-4.42M-3.77M-2.00M-3.47M-2.90M-3.52M-3.73M
Net Income towards Common Stockholders (Quarter)
-0.41M-3.69M-1.00M-0.90M-1.89M-8.39M-7.10M-2.45M-7.23M-9.46M-12.70M-3.24M-4.48M-4.42M-3.77M-2.00M-3.47M-2.90M-3.52M-3.73M
Additional items
EPS (Basic) (Quarter)
-9.78-95.70-24.01-21.57-45.25-255.50-136.19-40.97-90.18-109.10-47.30-10.26-10.96-11.80-4.38-1.77-1.32-1.40-0.90-0.95
EPS (Diluted) (Quarter)
-9.78-127.60-34.67-21.57-45.25-255.50-136.19-40.97-90.18-109.10-47.30-10.26-10.96-11.80-4.38-1.77-3.06-2.56-3.11-3.29
Shares Outstanding (Quarter)
0.04M0.04M0.04M0.04M0.04M0.03M0.05M0.06M0.08M0.09M0.27M0.32M0.41M0.37M0.86M1.13M2.64M2.07M3.92M3.92M
Shares Outstanding (Diluted) (Quarter)
0.04M0.03M0.03M0.04M0.04M0.03M0.05M0.06M0.08M0.09M0.27M0.32M0.41M0.37M0.86M1.13M1.13M1.13M1.13M1.13M
Shares Outstanding (Entity) (Quarter)
0.04M0.04M0.04M0.04M0.04M0.03M0.05M0.06M0.08M0.09M0.30M0.32M0.42M0.37M0.93M1.13M2.64M2.07M3.99M4.41M
EBITDA (Quarter)
-0.41M-3.70M-0.81M-1.31M-1.77M-7.72M-4.58M-3.75M-2.94M-2.94M-3.95M-4.67M-4.46M-4.77M-3.82M-1.76M-3.58M-3.02M-3.60M-3.79M
Interest Expenses (Quarter)
0.17M0.19M0.12M0.01M0.51M0.23M0.22M0.24M0.14M0.08M0.27M0.03M0.01M0.01M31.99M0.01M0.01M
Tax Rate (Quarter)
-0.05%-0.20%0.05%-0.09%-0.08%-0.03%-0.09%